IMAX (NYSE:IMAX) Issues Quarterly Earnings Results, Beats Estimates By $0.13 EPS

IMAX (NYSE:IMAX) posted its earnings results on Thursday. The company reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.30 by $0.13, FiscalAI reports. IMAX had a net margin of 9.84% and a return on equity of 15.65%. The firm had revenue of $102.84 million during the quarter, compared to analyst estimates of $96.09 million. During the same period in the previous year, the business posted $0.26 EPS. IMAX’s revenue was up 12.2% on a year-over-year basis.

Here are the key takeaways from IMAX’s conference call:

• IMAX said Q2 results beat consensus across key metrics, with revenue up 12% to $103 million, adjusted EPS up 65% to $0.43, and adjusted EBITDA of $48 million at a 46.6% margin.
• The Odyssey is driving extraordinary early box office performance, including a $52 million global opening, 75% domestic occupancy, and record weekday holds, which management says could make 2026 box office a record year for IMAX.
• Management highlighted a strong content pipeline for the back half of 2026 and into 2027, led by Dune: Part Three, Spider-Man: Brand New Day, and several other Filmed for IMAX and IMAX 70mm titles that could extend momentum.
• Exhibitor demand remains strong, with 38 system installations in Q2 and 36 system signings, while year-to-date signings reached 62, supporting continued global network expansion.
• IMAX is also pushing newer growth initiatives such as merchandising and an in-vehicle entertainment partnership in China, which management views as untapped opportunities but still early-stage.

IMAX Stock Down 1.7%

IMAX stock opened at $43.21 on Friday. The stock has a market cap of $2.38 billion, a P/E ratio of 60.02, a P/E/G ratio of 1.61 and a beta of 0.37. The company’s 50 day moving average price is $39.99 and its two-hundred day moving average price is $38.03. IMAX has a 52 week low of $24.20 and a 52 week high of $45.88.

Analyst Ratings Changes

IMAX has been the subject of a number of research analyst reports. JPMorgan Chase & Co. increased their target price on IMAX from $47.00 to $50.00 and gave the company an “overweight” rating in a report on Friday. The Goldman Sachs Group reissued a “neutral” rating and set a $42.00 price target on shares of IMAX in a research report on Thursday. HC Wainwright reaffirmed a “buy” rating on shares of IMAX in a report on Friday. Rosenblatt Securities reaffirmed a “buy” rating and set a $47.00 price target on shares of IMAX in a research report on Monday, July 20th. Finally, Benchmark restated a “buy” rating on shares of IMAX in a research report on Monday, June 22nd. Ten equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $50.36.

Insider Activity at IMAX

In other news, CEO Richard L. Gelfond sold 8,943 shares of the firm’s stock in a transaction that occurred on Monday, April 27th. The shares were sold at an average price of $37.33, for a total value of $333,842.19. Following the completion of the transaction, the chief executive officer directly owned 765,002 shares in the company, valued at approximately $28,557,524.66. This trade represents a 1.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 20.55% of the stock is owned by insiders.

Hedge Funds Weigh In On IMAX

Several hedge funds and other institutional investors have recently modified their holdings of IMAX. Orbis Allan Gray Ltd grew its position in IMAX by 31.7% in the 2nd quarter. Orbis Allan Gray Ltd now owns 5,113,033 shares of the company’s stock worth $142,960,000 after purchasing an additional 1,230,267 shares during the period. Balyasny Asset Management L.P. purchased a new stake in IMAX in the second quarter worth about $12,568,000. Nuveen LLC raised its holdings in IMAX by 253.0% in the fourth quarter. Nuveen LLC now owns 507,377 shares of the company’s stock worth $18,753,000 after purchasing an additional 363,658 shares in the last quarter. BNP Paribas Financial Markets boosted its stake in IMAX by 494.6% in the 3rd quarter. BNP Paribas Financial Markets now owns 377,207 shares of the company’s stock worth $12,354,000 after purchasing an additional 313,763 shares in the last quarter. Finally, Squarepoint Ops LLC increased its holdings in IMAX by 177.0% in the 2nd quarter. Squarepoint Ops LLC now owns 446,286 shares of the company’s stock worth $12,478,000 after buying an additional 285,184 shares during the period. 93.51% of the stock is owned by institutional investors.

Key Stories Impacting IMAX

Here are the key news stories impacting IMAX this week:

• Positive Sentiment: IMAX reported better-than-expected second-quarter results, with EPS and revenue both topping Wall Street estimates, while management reaffirmed full-year guidance and highlighted margin expansion and network growth. IMAX Corporation Reports Second Quarter 2026 Results
• Positive Sentiment: Strong box-office traction for The Odyssey is boosting confidence that IMAX can sustain higher ticket sales and premium-screen utilization, with reports suggesting the film could be a transformational release for the company. The Odyssey is cleaning up for IMAX. Expect the momentum to continue
• Positive Sentiment: Analysts turned more bullish after earnings, with JPMorgan, Wells Fargo, Barrington, and Wedbush all raising price targets, and Wedbush reiterating Outperform on expectations for a stronger film pipeline, market-share gains, and international expansion. IMAX price target boosted by Wedbush on growth outlook
• Positive Sentiment: Investor attention is also being reinforced by unusual call-option activity and multiple stories about sold-out IMAX 70mm showings, signaling strong near-term demand sentiment around the stock. Imax’s CEO says it’s time to hike prices as tickets to ‘The Odyssey’ resell for $1,000
• Neutral Sentiment: IMAX disclosed a new regulatory risk tied to geopolitical, trade, and other global expansion challenges, which could matter over time but does not appear to be driving near-term trading. IMAX Confronts Rising Geopolitical, Regulatory and Trade Risks Threatening Global Expansion

About IMAX

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.